• BioHarvest Sciences Inc. (BHSC) has announced that its flagship VINIA product, a non-GMO supplement containing the cells of red grapes, is launching in the United States as of May 12, 2021
  • VINIA contains all the benefits of red wine with the advantage of zero calories, zero sugar, and zero percent alcohol
  • Based in Vancouver, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology
  • BioHarvest Sciences Inc. (BHSC) is down 2.74 per cent and is currently trading at $0.355 per share

BioHarvest Sciences Inc. (BHSC) has announced that its flagship VINIA product is launching in the United States as of May 12, 2021.

VINIA is the first and only product in the world to contain levels of Piceid Resveratrol from red grapes equivalent to the amount of Piceid Resveratrol in the average bottle of red wine.

It contains all the benefits of red wine with the advantage of zero calories, zero sugar, and zero percent alcohol.
This milestone represents a turning point for BioHarvest as it brings its flagship product to the United States, the largest market in the world for nutraceutical supplements.
Ilan Sobel, CEO of BioHarvest, commented on the launch of the product.
“We are entering the US nutraceuticals market with a powerful science-based product which has the ability to contribute to the overall wellness of American consumers,” he said, adding, “Not only are we uniquely positioned to lead the established Resveratrol-based dietary supplements market, but we will also reach sizeable segments within this market, due to the heart health and energy enhancing benefits of VINIA.”
VINIA demonstrates a unique ability to support heart health and improve physical energy and mental alertness via increased blood flow and oxygen delivery to the body’s tissues and organs.
Based in Vancouver, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology, the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself.
BioHarvest Sciences Inc. (BHSC) is down 2.74 per cent and is trading at $0.355 per share as of 12:29 pm ET. 
More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

GameStop stock struggles on weak Q4 2023 performance

GameStop Corp. (NYSE:GME) stock struggles after reporting weak Q4 2023 financial results, but it eventually claws back some gains.